Revalor XS

SECTION 2: Hazards identification

OSHA EMERGENCY OVERVIEW Pellets Yellow Odor unknown May cause cancer. May cause impaired fertility. May cause harm to the unborn child. Prolonged exposure may cause serious health effects. Causes effects to: endocrine system May cause effects to: gastrointestinal tract central nervous system cardiovascular system male reproductive system female reproductive system breast fetus Harmful to aquatic life with long lasting effects.

Potential health effects

The toxicological properties of the mixture(s) have not been fully characterized in humans or animals. However, there are data to describe the toxicological properties of the individual ingredients. The following summary is based upon available information about the individual ingredients of the mixture(s), or of the expected properties of the mixture(s). Trenbolone acetate, an androgenic (anabolic) steroid, is harmful with prolonged or repeated exposure by inhalation, in contact with skin, or if swallowed. Symptoms of exposure may inlcude headache, gastrointestinal complaints, dizziness, tremor, sweating, vomiting, nausea, water retention and sodium retention. Effects of overexposure may include effects as for androgens in general: androgenic and anabolic activity, changes in libido, reversible gynecomastia in male, effects on fertility and effects on menstruation. Estradiol, an estrogen/oestrogen, is harmful with repeated or prolonged exposure by inhalation, skin absorption, or if swallowed. Symptoms of exposure may include headache, gastrointestinal complaints, nausea, dizziness, vomiting, diarrhea, water retention and sodium retention. Effects of overexposure may include effects as for estrogens in general: effects on menstruation in female, edema, reversible gynecomastia in male; may cause tenderness of breasts, changes in libido. Exposure to Estradiol may pose a possible risk of harm to the unborn child and may impair fertility. There is evidence of a carcinogenic effect. Estradiol is an estrogen hormone normally produced by the ovary and is a metabolite of testosterone. Adverse effects observed during clinical therapy with estradiol include central nervous system effects (e.g. headaches, dizziness, nervousness, mood disturbances, or irritability), changes in body weight, leg cramps, water retention, visual disturbances, gastrointestinal effects, cardiovascular effects (e.g. chest pain, increases in blood pressure, blood clots, heart attacks, or stroke), skin reactions (e.g. contact dermatitis, pruritus, or rash), or effects to breasts (e.g. tenderness, enlargement, or pain). Estrogens have also been shown to cause increased incidences in ovarian, breast, or endometrial cancer. Estrogen administration has been shown to decrease the quantity and quality of breast milk. Estrogens have also been shown to be present in breast milk. LISTED CARCINOGENS INGREDIENT CAS NUMBER